Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Remodulin (treprostinil sodium) Injection, 1.0, 2.5, 5.0, and 10.0 mg/ml United Therapeutics NDA 21-272 | Remodulin (treprostinil sodium) injection, United Therapeutics, Labeling Revision | Remodulin (treprostinil sodium) Injection, United Therapeutics, Accelerated Approval | Remodulin (treprostinil sodium) Injection, United Therapeutics, Labeling Revision | Remodulin (treprostinil sodium) Subcutaneous I.V. Injection, United Therapeutics Corp., Labeling Revision | Remodulin (treprostinil sodium) Subcutaneous I.V. Injection, United Therapeutics Corp., Labeling Revision | Remodulin (treprostinil sodium) I.V. Injection, United Therapeutics Corp., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News © 2010 Betterchem.com